top of page

Aesthetics and Cosmetic Surgery M&A Landscape

An overview of mergers & acquisitions and private equity investments into the UK aesthetics and cosmetic surgery markets.

An overview of M&A and private equity activity in the UK aesthetics and cosmetic surgery market

The UK aesthetics market is experiencing significant growth, driven by demographic trends, advances in technology, and evolving consumer attitudes towards cosmetic procedures. Valued at over £3.6 billion, this dynamic sector presents a compelling investment opportunity.

Social media platforms have normalised cosmetic enhancements, increasing their popularity across age groups. Innovations in non-surgical procedures such as injectables and LED therapy have made treatments safer, more effective, and more accessible, expanding the range of available options and improving patient satisfaction.

The anticipated introduction of a licensing regime for non-surgical procedures in England is set to raise safety and quality standards. With only around 1 in 4 UK aesthetics providers currently regulated, there is significant room for improvement. The British College of Aesthetic Medicine found that 82% of its members had to handle complications from treatments performed by less qualified practitioners, underlining the need for stricter regulations and higher standards. This regulatory shift is expected to boost demand for accredited training and high-standard practices, creating a favourable environment for reputable providers and investors.

Recent M&A activity highlights the attractiveness of the broader sector. Rockpool’s £8 million investment in Harley Academy, a leading training provider in aesthetic medicine, underscores the value of high-quality education in this evolving regulatory landscape. BGF’s investment in The Avoca Clinic, Ireland’s premier cosmetic surgery practice, aims to expand its footprint, reflecting confidence in the growth trajectory of established clinics. Foresight’s £7 million investment in KSL Clinic highlights the growth potential in niche areas like hair transplantation.

The market’s fragmentation, with many independent clinics and practices, also offers significant consolidation opportunities which are likely to be capitalised upon by a growing number of private equity-backed platforms. As a result, we expect to see growing M&A activity across the aesthetics and cosmetic surgery markets in the future.


bottom of page